Nanobio and Nanomedicine

NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.

Develops complete surface solutions for medical implants based on bionanotechnology.

Develops advanced biosensors, based on multidisciplinary knowledge in bio- and nanotechnology.

Nano Bridging Molecules is devoted to researching, developing, manufacturing, and marketing its patented SurfLink® range of advanced medical implant surface modifications designed to render medical implants biocompatible with the human body.

The company's core competence is to create high-definition bioactive protein coatings.

The company focused on delivering nanotechnology based innovative diagnostics products.

The company's objective is to develop methods to treat Calcifying Nanoparticles (CNPs), and by so doing find more effective approaches to the diseases associated with them.

A biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines, based on its nanotechnology platform.

NanoBioDesign is developing a range of innovative tools based upon its P450 technology. P450 enzymes are present in the human liver and are important for the metabolism of drugs. The company's "Liver Chip" will directly measure the kinetic parameters associated with drug metabolism in a fast, accurate, reproducible and cost effective way.

A nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies.

Develops nanobiotechnology platforms that address global healthcare needs.

NanoBiotech is a broad-based life science company that discovers, develops, manufactures and markets a range of nanobiotics and medical diagnostics designed to improve people's health and longevity.

Dedicated to finding new treatments for cancer based on the combined application of nanotechnologies and biotechnologies.

Applies the manufacturing technology of ultrafine particles termed 'micellar nanoparticles' to use them as carriers for drugs, such as anticancer agents.

Commercializes its proprietary process for creating advanced coatings and drug formulations through its ability to nanoformulate compounds and/or apply those novel formulations as coatings onto the surfaces of medical devices.

NanoCor intends to use its proprietary Biological Nanoparticle technology platform and a proprietary, patent-protected gene to provide Chronic Heart Failure patients worldwide with an effective, economic, and safe alternative.

Nanodetex Corporation is active in lab-on-chip platform technologies with its gas phase chemical analysis systems.

A Nanodisc is a proprietary nano-scale structure created using a process of self-assembly of a phospholipid bilayer disc surrounded by a patented, engineered membrane scaffold protein (MSP) belt. Nanodiscs render amphipathic and hydrophobic molecules easily soluble, offering transformative innovations across a broad range of commercial applications in both in vivo delivery of therapeutics, diagnostic and imaging agents as well as for in vitro drug discovery.

NanoDrop Technologies manufactures and sells unique analytical instruments based upon patented sample retention technology. These instruments are used globally in biotechnology, pharmaceutical and life science research.

Biomedical diagnostics products.

Offers a nanoencryption technology which is a layered pharmaceutical brand protection solution based on proprietary nanolithographic encryption technology.

NanoLife Holdings is focused on its mission of the development of a Global Initiative, the commitment of the world's scientific, economic, and political prowess to Saving Lives from the Ravages of Cancer. NanoLife is facilitating advanced developments in radiotherapy for cancer.

NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.

Nanolymf Ltd. is a subsidiary of Shizim Ltd. with the mission to meet the challenges of enhancing the bioavailability of highly lipophilic drugs, by introducing the market with a novel controlled release double layered nanoencapsulation delivery system.

Nanolytics is dedicated to making microfluidics just a tool in the biotechnology industry, using its state of the art Electro-Wetting Lab-on-a-Chip Technology, Nano-Dispensing Technology, Compact Nanoliter Volume PCR Machine.